Use filters to refine the search results.
Results 1-4 of 4
|5-Nov-2015||Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models||Penny, MA; Verity, RV; Bever, C; Sauboin, C; Galactionova, K, et al|
|19-Jun-2018||Synergy in anti-malarial pre-erythrocytic and transmission-blocking antibodies is achieved by reducing parasite density||Sherrard-Smith, E; Sala, KA; Betancourt, M; Upton, LM; Angrisano, F, et al|
|2-Sep-2015||Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial||White, MT; Verity, R; Griffin, JT; Asante, KP; Owusu-Agyei, S, et al|
|23-Oct-2015||Vaccine approaches to malaria control and elimination: Insights from mathematical models||White, MT; Verity, R; Churcher, TS; Ghani, AC; PATH-Program for Appropriate Technology in Health, et al|